- Accueil >
- Publications >
- Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study
Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study
Auteurs
J. Guigay, J. Fayette, A.F. Dillies, C. Sire, J.N. Kerger, I. Tennevet, J.P. Machiels, S. Zanetta, Y. Pointreau, L. Bozec Le Moal, S. Henry, A. Schilf, J. Bourhis